Literature DB >> 24070789

The STEP (Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version.

Smita Salunke1, Barbara Brandys, George Giacoia, Catherine Tuleu.   

Abstract

The screening and careful selection of excipients is a critical step in paediatric formulation development as certain excipients acceptable in adult formulations, may not be appropriate for paediatric use. While there is extensive toxicity data that could help in better understanding and highlighting the gaps in toxicity studies, the data are often scattered around the information sources and saddled with incompatible data types and formats. This paper is the second in a series that presents the update on the Safety and Toxicity of Excipients for Paediatrics ("STEP") database being developed by Eu-US PFIs, and describes the architecture data fields and functions of the database. The STEP database is a user designed resource that compiles the safety and toxicity data of excipients that is scattered over various sources and presents it in one freely accessible source. Currently, in the pilot database data from over 2000 references/10 excipients presenting preclinical, clinical, regulatory information and toxicological reviews, with references and source links. The STEP database allows searching "FOR" excipients and "BY" excipients. This dual nature of the STEP database, in which toxicity and safety information can be searched in both directions, makes it unique from existing sources. If the pilot is successful, the aim is to increase the number of excipients in the existing database so that a database large enough to be of practical research use will be available. It is anticipated that this source will prove to be a useful platform for data management and data exchange of excipient safety information.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACToR; ADI; AFSSAPS; Acceptable Daily Intake; Adverse effects; Agence française de sécurité sanitaire des produits de santé (French Agency for the Safety of Health Products); Aggregated Computational Toxicology Resource; CAS; CCOHS; Canadian Centre for Occupational Health and Safety; Chemical Abstracts Service; Chemicals; Children; Database; EFSA; ESIS; ESNEE; EuPFI; European Food Safety Authority; European Paediatric Formulation Initiative; European Study of Neonatal Excipient Exposure; European chemical Substances Information System; Excipients; FDA; Food and Drug Administration; GRAS; Generally Regarded As Safe; IPCS; IT; IUPAC; Information Technology; International Programme on Chemical Safety; International Union of Pure And Applied Chemistry; JECFA; Joint FAO/WHO Expert Committee on Food Additives; NLM; NRC; NTP; National Library of Medicine; National Research Council; National Toxicology Program database; PK/PD; Pharmacokinetics/Pharmacodynamics; STEP; Safety and Toxicity of Excipients for Paediatrics; SmPC; Summary of Product Characteristics; Toxicity; URL; US PFI; Uniform Resource Locator; United States Paediatric Formulation Initiative; WHO; World Health Organization

Mesh:

Substances:

Year:  2013        PMID: 24070789     DOI: 10.1016/j.ijpharm.2013.09.013

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  23 in total

Review 1.  Challenges Associated with Route of Administration in Neonatal Drug Delivery.

Authors:  Matthew W Linakis; Jessica K Roberts; Anita C Lala; Michael G Spigarelli; Natalie J Medlicott; David M Reith; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

Review 2.  Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.

Authors:  Maren Preis
Journal:  AAPS PharmSciTech       Date:  2015-03-05       Impact factor: 3.246

3.  Biopharmaceutical optimization in neglected diseases for paediatric patients by applying the provisional paediatric biopharmaceutical classification system.

Authors:  Jose Manuel Del Moral Sanchez; Isabel Gonzalez-Alvarez; Aaron Cerda-Revert; Marta Gonzalez-Alvarez; Andres Navarro-Ruiz; Gordon L Amidon; Marival Bermejo
Journal:  Br J Clin Pharmacol       Date:  2018-07-17       Impact factor: 4.335

4.  Toxic excipients in medications for neonates in Brazil.

Authors:  Alcidésio Souza; Djanilson Santos; Said Fonseca; Marina Medeiros; Lívia Batista; Mark Turner; Helena Coelho
Journal:  Eur J Pediatr       Date:  2014-02-06       Impact factor: 3.183

5.  Substitution as a Strategy to Improve Excipient Exposure in Neonates: One Piece of the Puzzle.

Authors:  Karel Allegaert; Isabel Spriet
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

6.  Development of a Pediatric Mini-Tablet Formulation for Expedited Preclinical Studies.

Authors:  Monika Lavan; Xueqi Wang; Robyn McCain; Amber Jannasch; Bruce Cooper; Scott Hostetler; Stephen Byrn; Gregory Knipp
Journal:  AAPS PharmSciTech       Date:  2021-01-08       Impact factor: 3.246

Review 7.  Neonatal drug therapy: The first frontier of therapeutics for children.

Authors:  K Allegaert; J van den Anker
Journal:  Clin Pharmacol Ther       Date:  2015-07-22       Impact factor: 6.875

8.  Furosemide ethanol-free oral solutions for paediatric use: formulation, HPLC method and stability study.

Authors:  Lukáš Zahálka; Sylva Klovrzová; Ludmila Matysová; Zdenka Šklubalová; Petr Solich
Journal:  Eur J Hosp Pharm       Date:  2017-08-02

9.  Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates.

Authors:  Georgi Nellis; Tuuli Metsvaht; Heili Varendi; Jana Lass; Jennifer Duncan; Anthony J Nunn; Mark A Turner; Irja Lutsar
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

10.  Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients.

Authors:  Lorrene A Buckley; Smita Salunke; Karen Thompson; Gerri Baer; Darren Fegley; Mark A Turner
Journal:  Int J Pharm       Date:  2017-07-17       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.